Skip to main content

About Crohn’s Disease

Crohn’s disease is a chronic inflammatory condition that most commonly affects the last segment of the small intestine (ileum) and the first part of the large intestine (caecum), although it can occur in any part of the GIT from the mouth to the anus. It is not uncommon for people with Crohn’s disease to have normal, healthy parts of tissue in between areas of inflammation. This has implications for how Crohn’s disease is treated, especially by surgery. Also, unlike ulcerative colitis, where the inflammation is limited to the innermost lining of the intestinal wall, in Crohn’s disease the inflammation can extend into the deeper layers, which can lead to the development of complications that are quite specific to the condition.

How does Crohn’s disease affect the intestines?

Crohn’s disease affects the GI tract, and the intestinal wall becomes inflamed (red and swollen). The inflammation can penetrate through all layers of the GI tract and may occur at one or more locations in the GI tract, from the mouth right through to the anus, with areas of normal tissue between areas of diseased tissue. Depending on the main areas of the intestine involved in Crohn’s disease, the condition can be referred to as:

  • Ileocolitis: involves the ileum and colon (small and large intestine)
  • Ileitis: involves the ileum only (small intestine only)
  • Crohn’s (granulomatous) colitis: involves the colon only (large intestine only)
  • Gastroduodenal Crohn’s disease: involves the stomach and duodenum (small intestine)
  • Jejunoileitis: involves the jejunum (small intestine only)

Additional Information:

The latest news and Research

News

Antioxidants in corn line could aid human IBD protection, therapy

Posted: July 13 2020

The researchers bred a novel line of corn at Penn State’s Russell E. Larson Agricultural Research Center to produce compounds called flavan-4-ols. The team then conducted an experiment with mice to judge the effect of those powerful antioxidant compounds on induced inflammation of the colon. “In this study, we utilized two corn lines­ – one […]

Read more

News

Real advice for parenting through UC

Posted: July 6 2020

Plan for Flares “I have a 6-month old, and I recently experienced a severe flare,” says Jamie D., of Chelan, WA. “I knew I was going to need a plan for when I was running to the bathroom 10 times a day on the days my husband was gone. (He’s a firefighter, so I’m home […]

Read more

Research

The microbiome in inflammatory bowel diseases

From pathogenesis to therapy.

Inflammatory bowel disease (IBD) has become a global disease with accelerating incidence worldwide in the 21st century while its accurate etiology remains unclear. In the past decade, gut microbiota dysbiosis has consistently been associated with IBD. Although many IBD-associated dysbiosis have not been proven to be a cause or an effect of IBD, it is […]

Read more

News

Cloning stem cells to find a cure for Crohn’s disease

Posted: July 6 2020

For over a decade, Wa Xian, research associate professor of biology and biochemistry at the University of Houston Stem Cell Center, has been perfecting technology for cloning stem cells. Now she is using it to take aim at pediatric Crohn’s disease. Xian, who received a $1.9 million grant from the National Institute of Diabetes and […]

Read more

News

Greater recurrence of CRC in late-onset vs early onset IBD

Posted: June 27 2020

These findings suggest a difference in colorectal cancer pathophysiology by age, according to the researchers. “Despite longer IBD disease duration at the time of colon or rectal cancer diagnosis, patients with early-onset IBD had significantly more advanced colitis at the time of diagnosis of colon and rectal cancer,” Robert Goldstone, MD, Massachusetts General Hospital general and GI surgeon, […]

Read more

News

‘Important’ microbiome studies offer hope for IBD prediction

Posted: June 26 2020

We may be able to predict disease relapse in patients with chronic inflammatory bowel diseases based on their microbiome markers, according researchers from APC Microbiome Ireland. Read ‘Important’ microbiome studies offer hope for IBD prediction by Nikki Hancocks

Read more